Nancy Lurker
Director/Board Member chez EYEPOINT PHARMACEUTICALS, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Nancy Sue Lurker is currently the Executive Vice Chairman at EyePoint Pharmaceuticals, Inc. since 2023.
She is also the Director at Altasciences Co., Inc. since 2021 and the Independent Director at Alkermes Plc since 2024.
Previously, Ms. Lurker held the position of President, Chief Executive Officer & Director at Interpace Biosciences, Inc. from 2011 to 2015.
She was also the President & Chief Executive Officer at ImpactRx, Inc. from 2003 to 2006 and at Pdi, Inc. (United States) from 2008 to 2015.
Additionally, she served as the Chairman at X4 Pharmaceuticals, Inc. from 2016 to 2018.
Ms. Lurker has a background in the pharmaceutical industry, having worked as the Senior Director-Worldwide Cardiovascular Franchise at Bristol Myers Squibb Co. in 1998.
She also served as a Director at Elan Corp.
Plc in 2005 and at Elan Pharmaceuticals LLC in 2006.
Furthermore, she was an Independent Director at Auxilium Pharmaceuticals LLC from 2011 to 2015, an Independent Director at Aquestive Therapeutics, Inc. from 2018 to 2022, and an Independent Director at Mallinckrodt Plc from 2013 to 2016.
Ms. Lurker holds an undergraduate degree from Seattle Pacific University and an MBA from the University of Evansville.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/02/2024 | 210 240 ( 0,42% ) | 4 M $ | 31/03/2024 |
Postes actifs de Nancy Lurker
| Sociétés | Poste | Début |
|---|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 15/09/2016 |
| ALKERMES PLC | Director/Board Member | 07/03/2024 |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Director/Board Member | 01/04/2021 |
Anciens postes connus de Nancy Lurker
| Sociétés | Poste | Fin |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Director/Board Member | 22/06/2022 |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Chairman | 01/01/2018 |
| MALLINCKRODT PLC | Director/Board Member | 21/07/2016 |
| INTERPACE BIOSCIENCES, INC. | Chief Executive Officer | 22/12/2015 |
| Pdi, Inc. (United States) | Chief Executive Officer | 01/12/2015 |
Formation de Nancy Lurker
| Seattle Pacific University | Undergraduate Degree |
| University of Evansville | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 12 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services ImpactRx, Inc. was provided health-care sector custom research and promotional consultancy services. The company was founded by Lawrence G. Miller, Terry Overton and Gerald J. Gallivan in 2000 and was headquartered in Horsham, PA. | Commercial Services |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Cancer Treatment Centers of America, Inc.
 Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Health Services |
| National Physicians Corp. | |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Health Technology |
Altasciences Co., Inc.
Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Commercial Services |
| Pdi, Inc. (United States) |
